Sign Up to like & get
recommendations!
1
Published in 2017 at "Targeted Oncology"
DOI: 10.1007/s11523-017-0513-6
Abstract: Unlike for adenocarcinomas of the lung, no molecular targeted therapies have yet been developed for squamous cell lung cancers, because targetable oncogenic aberrations are scarce in this tumor type. Recent discoveries have established that the…
read more here.
Keywords:
targeting fgfr;
squamous cell;
cell lung;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2021.102170
Abstract: Cholangiocarcinomas (CCAs) are rare but aggressive tumours of the bile ducts, which are often diagnosed at an advanced stage and have poor outcomes on systemic therapy. Somatic alterations with therapeutic implications have been identified in…
read more here.
Keywords:
targeting fgfr;
inhibition;
inhibition cholangiocarcinoma;
fgfr inhibitors ... See more keywords